PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

Borchmann, P; Plutschow, A; Kobe, C; Greil, R; Meissner, J; Topp, MS; Ostermann, H; Dierlamm, J; Mohm, J; Thiemer, J; Sokler, M; Kerkhoff, A; Ahlborn, M; Halbsguth, TV; Martin, S; Keller, U; Balabanov, S; Pabst, T; Vogelhuber, M; Huttmann, A; Wilhelm, M; Zijlstra, JM; Moccia, A; Kuhnert, G; Brockelmann, PJ; von Tresckow, B; Fuchs, M; Klimm, B; Rosenwald, A; Eich, H; Baues, C; Marnitz, S; Hallek, M; Diehl, V; Dietlein, M; Engert, A

View this publication in the PUBMED database